ARTICLE | Clinical News
NGAL Test: Clinical trial completed enrollment
April 20, 2015 7:00 AM UTC
BioPorto completed enrollment of 250 ICU patients in a blinded, U.S. clinical trial comparing its NGAL Test vs. clinical diagnosis of AKI as determined by Kidney Disease Improving Global Outcomes (KDI...